Patients Gain Greater Access to Endari Through Telehealth Partnership

Patients Gain Greater Access to Endari Through Telehealth Partnership

312736

Patients Gain Greater Access to Endari Through Telehealth Partnership

Through a new partnership between Emmaus Life Sciences and UpScript, patients with sickle cell disease (SCD) will soon be able to consult with a physician from home and have greater access to Endari (L-glutamine). Through telehealth — using computers and mobile devices to manage and receive healthcare services remotely — patients will be able to skirt the risks for infection that accompany hospital visits. The service is expected to begin within the next few months.…

You must be logged in to read/download the full post.